The market size of the Global Nicotinamide Adenine Dinucleotide Market in the year 2021 is valued at 451.93 million and is predicted to reach 1285.44 million by the year 2030 at an 12.57% CAGR during the forecast period.
The crucial pyridine nucleotide nicotinamide adenine dinucleotide (NAD+) is required for several critical cellular processes, including DNA repair, epigenetically regulated gene expression, intracellular calcium signaling, and immunological functions. It also acts as an essential cofactor and substrate for these processes. One of the most well-known NAD supplements in contemporary biological research is NADH, a mitochondrial hormone that lengthens cells' life cycles (anti-aging). The nicotinamide adenine dinucleotide market is primarily driven by increased customer demand for anti-aging products and growing knowledge of NAD's advantages in enhancing metabolism. Leading scientific investigations into the value of NAD for human health are encouraging product prospects. The nicotinamide adenine dinucleotide market is projected to expand due to rising pharmaceutical usage and demand.
Moreover, the product acceptance rate is also greatly influenced by ongoing R&D projects to enhance the impact of NADH or NAD+ on metabolism to provide therapeutic intervention in inflammatory illnesses. However, strict government dosage controls to prevent harmful health effects are expected to limit industry growth. The regulatory agencies of many countries have only designated NAD as OTC because the dosage and course of treatment impact how effective it is.
The nicotinamide adenine dinucleotide market is segmented on grade and application. Based on grade, the market is segmented into food, pharmaceutical, and others. Based on application, the nicotinamide adenine dinucleotide market is segmented into dietary supplements, pharmaceuticals, anti-aging products and others.
Based on grade, the food grade segment is accounted as a major contributor to the nicotinamide adenine dinucleotide market.
Based on grade, the market is segmented into food, pharmaceutical, and others. The food grade category grabbed the highest revenue share, and it is anticipated that it will continue to hold that position during the anticipated time. The usage of NAD in the food and beverage business has increased dramatically due to its antioxidant characteristics, which has increased demand for NAD of the food grade. The significant role of NAD as a substrate and cofactor for numerous essential biological processes, such as DNA repair and epigenetically controlled gene expression, is anticipated to propel the market further.
The pharmaceuticals segment witnessed growth at a rapid rate
Based on application, the nicotinamide adenine dinucleotide market is segmented into dietary supplements, pharmaceuticals, anti-aging products and others. The pharmaceuticals category is anticipated to grow significantly over the forecast period. The demand for NAD among pharmaceutical producers is fueled by the popularity of NAD as an active component in the manufacturing process of numerous health medications. Due to the effectiveness of NAD-boosting drugs in repairing DNA damage and modifications to prevent diseases like Alzheimer's disease, dementia, and Parkinson's disease, there is expected to be a significant demand for NAD in the pharmaceutical industry by 2030, pushing the segment's revenue to over USD 135 million.
The North America nicotinamide adenine dinucleotide market holds a significant revenue share in the region.
The North American nicotinamide adenine dinucleotide market is expected to register the highest market share in revenue soon. The presence of several NAD-based product manufacturing facilities and feed manufacturing firms are key factors influencing area industry statistics. Furthermore, the increased demand for NADH in North America results from the increasing prevalence of disorders brought on by an imbalance in the levels of NAD in the blood. Additionally, the Asia Pacific is anticipated to expand at a significant rate over the course of the forecast period. The consumer's increasing awareness of the health benefits is an important factor supporting the local market's growth. Additionally, the increased prevalence of cardiovascular illness in the area would spur demand for nicotinamide adenine dinucleotide (NAD), driving the development of the market for NAD.
Some major key players in the nicotinamide adenine dinucleotide market are Bontac Bioengineering, Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., F. Hoffmann-La Roche Ltd, HiMedia Laboratories, NutriScience Innovations, LLC, Nutrifoods, Bontac Bio-engineering(shenzhen)co.,ltd, Krackeler Scientific, Shandong Lankang Bio-Technology Co., Ltd., OYC Americas, Inc., Xi'an Yinherb Bio-Tech Co., Ltd, Shenzhen Hygieia Biotechnology Co., Ltd, Zhejiang Dazhan Biotechnology Co., Ltd., Otto Chemie Pvt. Ltd., and Uthever